Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
17
×
clinical trials
17
×
life sciences
national blog main
startups
17
×
biotech
national top stories
new york blog main
fda
new york top stories
san francisco blog main
indiana blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
indiana top stories
investing
national
raleigh-durham top stories
san diego top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
boston
cancer immunotherapy
glaxosmithkline
medical device
bristol-myers squibb
nonalcoholic steatohepatitis
What
roundup
bio
new
biotech
drug
drugs
medicines
therapeutics
cancer
companies
disease
million
nash
news
ago
ahead
aiming
alzheimer’s
annual
asco
attention
black
cash
clinical
closed
company
days
debut
developing
diabetes
diamond’s
digital
fda
focus
growing
key
potential
raises
research
rises
Language
unset
Current search:
startups
×
" clinical trials "
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More